100% (1)
page:
5 pages/≈1375 words
Sources:
5
Style:
APA
Subject:
Health, Medicine, Nursing
Type:
Research Paper
Language:
English (U.S.)
Document:
MS Word
Date:
Total cost:
$ 29.16
Topic:

Therapy for Patients with Impulsive/Substance Use Disorders (SUD)

Research Paper Instructions:

Week 10: Therapy for Patients With Impulsive/Substance Use Disorders (SUD)

Impulsivity and compulsivity have a wide range of clinical presentations and often overlap with many other psychiatric disorders. Some individuals act without forethought and have difficulty saying “no” to certain things, such as using illicit drugs or spending money, whereas other individuals engage in compulsive behaviors with undesirable consequences. In some cases, these impulsive and compulsive behaviors also fuel issues with addiction. To effectively assess and treat patients, you must understand how these disorders differ as well as how their symptoms impact patients and their families.  

This week, as you examine therapies for individuals with impulsivity, compulsivity, and addiction, you explore the assessment and treatment of patients with these disorders. You also consider ethical and legal implications of these therapies.

Learning Objectives

Students will:

Assess patient factors and history to develop personalized therapy plans for patients with impulsivity, compulsivity, and addiction

Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring therapy for impulsivity, compulsivity, and addiction

Synthesize knowledge of providing care to patients presenting for impulsivity, compulsivity, and addiction

Analyze ethical and legal implications related to prescribing therapy for patients with impulsivity, compulsivity, and addiction


Learning Resources

   

Required Readings (click to expand/reduce)


Kelly, J. E., & Renner, J. A. (2016). Alcohol-Related disorders. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 163–182). Elsevier.

Renner, J. A., & Ward, N. (2016). Drug addiction. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 163–182). Elsevier.

   

Substance Abuse and Mental Health Services Administration. (1999). Treatment of adolescents with substance use disorders: Treatment improvement protocol series, no. 32. http://www.ncbi.nlm.nih.gov/books/NBK64350/

Chapter 1, “Substance Use Among Adolescents”

Chapter 2, “Tailoring Treatment to the Adolescent’s Problem”

Chapter 7, “Youths with Distinctive Treatment Needs”

    

University of Michigan Health System. (2016). Childhood trauma linked to worse impulse control. Journal of Psychosocial Nursing & Mental Health Services, 54(4), 15.

    

Grant, J. E., Odlaug, B. L., & Schreiber, L. N. (2014). Pharmacological treatments in pathological gambling. British Journal of Clinical Pharmacology, 77(2), 375–381. https://doi.org/10.1111/j.1365-2125.2012.04457.x

    

Hulvershorn, L. A., Schroeder, K. M., Wink, L. K., Erickson, C. A., & McDougle, C. J. (2015). Psychopharmacologic treatment of children prenatally exposed to drugs of abuse. Human Psychopharmacology, 30(3), 164–172. https://doi.org/10.1002/hup.2467

    

Loreck, D., Brandt, N. J., & DiPaula, B. (2016). Managing opioid abuse in older adults: Clinical considerations and challenges. Journal of Gerontological Nursing, 42(4), 10–15. https://doi.org/10.3928/00989134-20160314-04

    

Salmon, J. M., & Forester, B. (2012). Substance abuse and co-occurring psychiatric disorders in older adults: A clinical case and review of the relevant literature. Journal of Dual Diagnosis, 8(1), 74–84. https://doi.org/10.1080/15504263.2012.648439

 

Sanches, M., Scott-Gurnell, K., Patel, A., Caetano, S. C., Zunta-Soares, G. B., Hatch, J. P., Olvera, R., Swann, A. C., & Soares, J. C. (2014). Impulsivity in children and adolescents with mood disorders and unaffected offspring of bipolar parents. Comprehensive Psychiatry, 55(6), 1337–1341. https://doi.org/10.1016/j.comppsych.2014.04.018


 

Medication Resources (click to expand/reduce)


 

U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm


Note: To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.

naltrexone (revia/vivitrol)

naloxone

acamprosate

disulfiram

 

Required Media (click to expand/reduce)


 

Case Study: A Puerto Rican Woman with Comorbid Addiction 
Note: This case study will serve as the foundation for this week’s Assignment.


 

Optional Resources (click to expand/reduce)



Assignment 1: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction

Impulsivity, compulsivity, and addiction are challenging disorders for patients across the life span. Impulsivity is the inclination to act upon sudden urges or desires without considering potential consequences; patients often describe impulsivity as living in the present moment without regard to the future (MentalHelp.net, n.d.). Thus, these disorders often manifest as negative behaviors, resulting in adverse outcomes for patients. For example, compulsivity represents a behavior that an individual feels driven to perform to relieve anxiety (MentalHelp.net, n.d.). The presence of these behaviors often results in addiction, which represents the process of the transition from impulsive to compulsive behavior.

In your role as the psychiatric nurse practitioner (PNP), you have the opportunity to help patients address underlying causes of the disorders and overcome these behaviors. For this Assignment, as you examine the client case study in this week’s Learning Resources, consider how you might assess and treat clients presenting with impulsivity, compulsivity, and addiction.

Reference: MentalHelp.net. (n.d.). Impaired decision-making, impulsivity, and compulsivity: Addictions’ effect on the cerebral cortex. https://www.mentalhelp.net/addiction/impulsivity-and-compulsivity-addictions-effect-on-the-cerebral-cortex/

To prepare for this Assignment:

Review this week’s Learning Resources, including the Medication Resources indicated for this week.

Reflect on the psychopharmacologic treatments you might recommend for the assessment and treatment of patients requiring therapy for impulsivity, compulsivity, and addiction.

The Assignment: 5 pages

Examine Case Study: A Puerto Rican Woman With Comorbid Addiction. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.

At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each

option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.

Introduction to the case (1 page)

Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.

Decision #1 (1 page)

Which decision did you select?

Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).

Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #2 (1 page)

Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).

Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #3 (1 page)

Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).

Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Conclusion (1 page)

Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.

 

CITE ALL WORK AND PROVIDE REFERENCES /PAGE

Research Paper Sample Content Preview:

Therapy for Patients with Impulsive/Substance Use Disorders (SUD)
Introduction
Impulsivity and compulsivity are correlatives and primary contributors to long-term behavioral addiction. Broadly, impulsivity frequently influences behavioral addiction, while compulsivity initiates conditional maintenance. Others define impulsivity as premature and unduly actions that connote unintended outcomes. Compulsivity, on the contrary, is the tendency towards recurring habits despite their negative consequences. Addiction is the transition and coordination from impulsive to compulsive actions. Therefore, impulsivity happens in the early phases of addiction; however, the compulsive aspect occurs when the change takes place, causing the individual to no longer trail their addiction exclusively for pleasure but coerces them to engage in addictive behaviors to curb their anxiousness and uncomfortable feelings.
For this paper, the case study involves a female from Puerto Rico, 53 years old presented to a clinic due to an “embarrassing problem” being an alcoholic from her early 20s after her father’s death. According to the report, the client has had ‘on and off” Alcohol Anonymous symptoms for over 25 years. Her gambling addiction has made it difficult for her to maintain sobriety over the past two years. This addiction was fueled by a casino that started operating near her home, which exclusively led her to increase cigarette smoking, and she is more concerned with the adverse health outcomes of cigarette smoking. The primary aim of this paper is to uncover means of assessing and constructing customized therapy procedures for clients with impulsivity, exclusivity, as well as addiction relying on the prescription and medication decisions of the client; the impact of pharmacodynamic and pharmacokinetic while considering legal and ethical ramifications linked to adopting the therapy for clients with impulsivity, exclusivity, and addiction.
Decision 1
The first decision adopted is subjecting the client to 380 mg of Vivitrol (Naltrexone) injection to the gluteal region intramuscularly every four weeks. The drug (Naltrexone) is primarily prescribed for alcohol addiction and operates by lowering the consumption of alcohol through opioid modulation systems, hence; minimizing the substantial impacts of alcohol. Food and Drug Agency (FDA) 2006 approved that Naltrexone injection usage could address the issues of submission with oral Naltrexone and should be administered monthly rather than daily to eliminate the urge of self-dosing and minimize the chances for users to discontinue the prescription impulsively. Several side effects are linked with Naltrexone injection, such as difficulty sleeping, vomiting, abdominal pain and cramps, nausea, anxiety, tiredness, and headaches (American Addiction Centers, 2022). The other treatment options for this patient, like 666 mg Acamprosate (Campral), administered orally three times a day, and 250 mg Disulfiram (Antabuse) administered orally daily, do not suffice in this context. This is because they are effective only in maintaining a patient from alcohol abstinence. For instance, if the client is approved to use Antabuse, the patient could experience side effects like alcohol toxicity after taking alcohol (American Addiction Centers, 2022). For Campral, the client’s weight (122 lbs) does not allow her to use the drug. The drug is permitted only to those above 132 lbs; thus, she would have to receive four tablets daily instead of six.
The purpose of choosing Vivitrol injections is to decrease alcohol cravings from the patient with unwanted side effects and long-term relapses. Naltrexone injections become effective within a few days, but the intended outcomes may last weeks. As witnessed, the client returned to the clinic after four weeks revealing that she felt ‘wonderful’ and had not craved to go to the casino and get alcohol. In order to be in a better place to respond to ethical dilemmas, the treatment plan incorporated informed consent communication with the patient. The decision was influenced by the ethical practice of psychopharmacology-improving the lives of individuals with substance use disorders through effective psychotropic prescription.
Decision 2
This decision entails making a referral for the client to receive further services and care from professional therapist to mitigate the issue of gambling. The patient responded well to medical interventions, but the gambling issues need further attention. According to commentators, quitting gambling is challenging but could be lessened through group treatment and support programs. Therefore, the first step is for the client to acknowledge that gambling is a problem for them, like in our case. With persistent counseling, the expert will uncover the pathologic causes of gambling. One leading cause of gambling addiction, according to the American Addiction Center, is residing in settings where gambling is largely auctioned, which enhances opportunities for one to become a primary compulsive gambler (American Addiction Centers, 2022). In this vein, the client got hooked to the game after going to a recently operating casino with a friend. Another suitable place to refer this client is to support groups where she can interact with fellow gamblers and share her experience, hope, and outcomes to solve the common problem (Salmon & Forester, 2012). Since the client complained of anxiety (a side effect of Naltrexone injection), formal patient education should be an ethical and legal considerati...
Updated on
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now:

👀 Other Visitors are Viewing These APA Essay Samples:

Sign In
Not register? Register Now!